GF Fund Management’s Phibro Animal Health PAHC Stock Holding History

GF Fund Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8K	Sell	440 -19	-4%	-$802	﹤0.01%	516
2026 Q1	$25.4K	Buy	459 +58	+14%	+$2.76K	﹤0.01%	472
2025 Q4	$15K	Sell	401 -42	-9%	-$1.71K	﹤0.01%	541
2025 Q3	$17.9K	Sell	443 -77	-15%	-$2.54K	﹤0.01%	504
2025 Q2	$13.3K	Hold	520	–	–	﹤0.01%	539
2025 Q1	$11.1K	Buy	520 +93	+22%	+$2.08K	﹤0.01%	553
2024 Q4	$8.97K	Buy	+427	New	+$9.88K	﹤0.01%	562

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GF Fund Management's PAHC Position: Q2 2026 in Review

GF Fund Management reduced its Phibro Animal Health (PAHC) stake by 4.1% in Q2 2026, selling an estimated $802 and leaving 440 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

GF Fund Management first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.4K in Q1 2026. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

GF Fund Management held 440 shares of Phibro Animal Health worth $13.8K as of Q2 2026.
GF Fund Management sold 19 Phibro Animal Health shares in Q2 2026, an estimated $802.
Phibro Animal Health made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #516 holding.
GF Fund Management first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Phibro Animal Health position peaked at $25.4K in Q1 2026.
209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.